Integral Diagnostics Ltd. (IDX) Share Forecast & Price Target

Compare

34 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

IDX Analyst Ratings

Strong Buy

5 Buy

0 Hold

0 Sell

Based on 5 analysts giving stock ratings to

Integral

Diagnostics Ltd.

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

IDX Stock 12 Month Forecast

Average Price Target

AU$3.44

▲(40.41% Upside)

Based on 5 Wall Street analysts offering 12 month price targets for Integral Diagnostics Ltd. in the last 3 months. The average price target is AU$3.44 with a high forecast of AU$4.00 and a low forecast of AU$3.20. The average price target represents a 40.41% change from the last price of AU$2.45.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"AU$1","2":"AU$2","3":"AU$3","4":"AU$4","5":"AU$5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">AU$4.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.44,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">AU$3.44</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">AU$3.20</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,2,3,4,5],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.57,2.6799999999999997,2.79,2.9,3.01,3.12,3.23,3.34,3.45,3.56,3.67,3.7800000000000002,3.89,{"y":4,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.57,2.6369230769230767,2.7038461538461536,2.770769230769231,2.8376923076923077,2.9046153846153846,2.9715384615384615,3.0384615384615383,3.105384615384615,3.172307692307692,3.239230769230769,3.306153846153846,3.373076923076923,{"y":3.44,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.57,2.6184615384615384,2.666923076923077,2.7153846153846155,2.7638461538461536,2.812307692307692,2.8607692307692307,2.9092307692307693,2.957692307692308,3.0061538461538464,3.054615384615385,3.103076923076923,3.1515384615384616,{"y":3.2,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2.78,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.84,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.04,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.08,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.24,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.37,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.41,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.5,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.64,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.89,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.76,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.59,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.57,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price TargetAU$4.00

Average Price TargetAU$3.44

Lowest Price TargetAU$3.20

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Shane Storey

Canaccord Genuity

AU$3.2

Buy

30.61%

Upside

Reiterated

12/08/25

Canaccord Genuity Reaffirms Their Buy Rating on Integral Diagnostics Ltd. (IDX)

Rachael Harwood

Macquarie

AU$3.4

Buy

38.78%

Upside

Reiterated

12/02/25

Steven Wheen

Jarden

AU$3.3

Buy

34.69%

Upside

Reiterated

11/26/25

Jarden Sticks to Their Buy Rating for Integral Diagnostics Ltd. (IDX)

Tom Godfrey

Ord Minnett

AU$3.3

Buy

34.69%

Upside

Reiterated

11/04/25

Ord Minnett Remains a Buy on Integral Diagnostics Ltd. (IDX)

Martyn Jacobs

Bell Potter

AU$4

Buy

63.27%

Upside

Reiterated

11/02/25

David Low

J.P. Morgan

AU$3.25→AU$3.4

Buy

38.78%

Upside

Reiterated

08/27/25

J.P. Morgan Sticks to Their Buy Rating for Integral Diagnostics Ltd. (IDX)

Craig Wong-Pan

RBC Capital

AU$3.3→AU$3.45

Buy

40.82%

Upside

Reiterated

08/27/25

Integral Diagnostics Ltd. (IDX) Gets a Buy from RBC CapitalRBC Capital analyst Craig Wong-Pan raised the price target on Integral Diagnostics Ltd (IDX:AU) to AUD3.45 (from AUD3.30) while maintaining a Outperform rating.

David Stanton

Jefferies

AU$3.3→AU$3.5

Buy

42.86%

Upside

Reiterated

08/26/25

Jefferies Sticks to Its Buy Rating for Integral Diagnostics Ltd. (IDX)Jefferies analyst David Stanton raised the price target on Integral Diagnostics Ltd (IDX:AU) to AUD3.50 (from AUD3.30) while maintaining a Buy rating.

Mathieu Chevrier

Citi

AU$2.7

Buy

10.20%

Upside

Upgraded

03/05/25

Positive Report for Integral Diagnostics Ltd. (IDX) from Citi

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Shane Storey

Canaccord Genuity

AU$3.2

Buy

30.61%

Upside

Reiterated

12/08/25

Canaccord Genuity Reaffirms Their Buy Rating on Integral Diagnostics Ltd. (IDX)

Rachael Harwood

Macquarie

AU$3.4

Buy

38.78%

Upside

Reiterated

12/02/25

Steven Wheen

Jarden

AU$3.3

Buy

34.69%

Upside

Reiterated

11/26/25

Jarden Sticks to Their Buy Rating for Integral Diagnostics Ltd. (IDX)

Tom Godfrey

Ord Minnett

AU$3.3

Buy

34.69%

Upside

Reiterated

11/04/25

Ord Minnett Remains a Buy on Integral Diagnostics Ltd. (IDX)

Martyn Jacobs

Bell Potter

AU$4

Buy

63.27%

Upside

Reiterated

11/02/25

David Low

J.P. Morgan

AU$3.25→AU$3.4

Buy

38.78%

Upside

Reiterated

08/27/25

J.P. Morgan Sticks to Their Buy Rating for Integral Diagnostics Ltd. (IDX)

Craig Wong-Pan

RBC Capital

AU$3.3→AU$3.45

Buy

40.82%

Upside

Reiterated

08/27/25

David Stanton

Jefferies

AU$3.3→AU$3.5

Buy

42.86%

Upside

Reiterated

08/26/25

Mathieu Chevrier

Citi

AU$2.7

Buy

10.20%

Upside

Upgraded

03/05/25

Positive Report for Integral Diagnostics Ltd. (IDX) from Citi

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Integral Diagnostics Ltd.

1 Month

xxx

Success Rate

8/15 ratings generated profit

Average Return

+0.87%

reiterated a xxx

rating 17 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 53.33% of your transactions generating a profit, with an average return of +0.87% per trade.

3 Months

xxx

Success Rate

5/7 ratings generated profit

Average Return

-1.89%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 71.43% of your transactions generating a profit, with an average return of -1.89% per trade.

1 Year

Tom GodfreyOrd Minnett

Success Rate

6/10 ratings generated profit

Average Return

+7.02%

reiterated a buy rating last month

Copying Tom Godfrey's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +7.02% per trade.

2 Years

xxx

Success Rate

5/10 ratings generated profit

Average Return

+1.17%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +1.17% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

IDX Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, IDX has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. IDX average Analyst price target in the past 3 months is 3.44.

Each month's total comprises the sum of three months' worth of ratings.

IDX Financial Forecast

IDX Earnings Forecast

Next quarter’s earnings estimate for IDX is AU$0.07 with a range of AU$0.06 to AU$0.07. The previous quarter’s EPS was AU$0.07. IDX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year IDX has Performed in-line its overall industry.

IDX Sales Forecast

Next quarter’s sales forecast for IDX is AU$396.28M with a range of AU$393.40M to AU$400.30M. The previous quarter’s sales results were AU$374.34M. IDX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year IDX has Performed in-line its overall industry.

IDX Stock Forecast FAQ

What is AU:IDX’s average 12-month price target, according to analysts?

Based on analyst ratings, Integral Diagnostics Ltd.’s 12-month average price target is 3.44.

What is AU:IDX’s upside potential, based on the analysts’ average price target?

Integral Diagnostics Ltd. has 40.41% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Integral Diagnostics Ltd. a Buy, Sell or Hold?

Integral Diagnostics Ltd. has a consensus rating of Strong Buy, which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.

What is Integral Diagnostics Ltd.’s share price target?

The average share price target for Integral Diagnostics Ltd. is 3.44. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is AU$4.00 ,and the lowest forecast is AU$3.20. The average share price target represents 40.41% Increase from the current price of AU$2.45.

What do analysts say about Integral Diagnostics Ltd.?

Integral Diagnostics Ltd.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.

How can I buy shares of Integral Diagnostics Ltd.?

To buy shares of AU:IDX, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Integral Diagnostics Ltd. (IDX) Share Forecast & Price Target

IDX Analyst Ratings

IDX Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Integral Diagnostics Ltd.

IDX Analyst Recommendation Trends

IDX Financial Forecast

IDX Earnings Forecast

IDX Sales Forecast

IDX Stock Forecast FAQ

Detailed List of Analyst Forecasts